Prescription Drug User Fee Act Date
Iovance’s cell therapy for skin cancer faces three-year delay due to FDA issues
Anika Sharma
The FDA has introduced a new twist in the ongoing Iovance Biotherapeutics saga, causing further delays in the approval process ...
